Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Apollo Hospitals Enterprise Limited, together with its subsidiaries, engages in the provision of healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, orthopedics, oncology, neurosciences, emergency, robotic surgery, and transplants; and cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatric, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, neurosurgery, radiology, plastic-surgery, neonatology, vascular-surgery, psychiatry, dentistry, ear, nose, and throat care, as well as genomic medicines. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, dialysis centers, cradle and fertility centers, diabetes management centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. Further, the company engages in the business of bio-banking of tissues. It serves through national retail healthcare centers and genomics institutes, as well as Apollo 24/7, a digital health mobile platform; and www.apollopharmacy.in, an online pharmacy. The company was incorporated in 1979 and is based in Chennai, India.

Revenue projections:

Revenue projections for APOLLOHOSP
Revenue projections for APOLLOHOSP

APOLLOHOSP's projected revenue decline from last year is likely to make investors cautious. Lower revenues often hurt a company's bottom line, leading investors to be concerned about the company's ability to maintain profitability and deliver strong financial results in the future.

Financial Ratios:

currentRatio 0.000000
forwardPE 45.930485
debtToEquity 83.606000
earningsGrowth 0.350000
revenueGrowth 0.172000
grossMargins 0.342570
operatingMargins 0.115190
trailingEps 125.240000
forwardEps 166.556050

Apollo Hospitals Enterprise Limited's high debt-to-equity ratio points to a heavily leveraged company. With more debt than equity, Apollo Hospitals Enterprise Limited may face increased financial risk, especially if its earnings or cash flow come under pressure.
Apollo Hospitals Enterprise Limited's positive earnings and revenue growth indicate that the company is on track to expand its business. This growth suggests a strong financial outlook, with increasing profits and sales positioning Apollo Hospitals Enterprise Limited for continued success in the market.
APOLLOHOSP's forward EPS exceeding its trailing EPS reflects expectations of increased profitability for the current year. This suggests that the company is projected to achieve higher earnings than in the previous financial year, signaling positive growth and improved financial health.

Price projections:

Price projections for APOLLOHOSP
Price projections for APOLLOHOSP

APOLLOHOSP's price projections have been revised upward over time, suggesting that analysts are becoming more confident in the company's future. This trend points to increased optimism about APOLLOHOSP's ability to grow.

Insider Transactions:

Insider Transactions for APOLLOHOSP
Insider Transactions for APOLLOHOSP


3 purchases of APOLLOHOSP were executed, with market price of 6553.183268229167.No buy transactions were carried out during the period under review.APOLLOHOSP's current price levels are marked by increased selling, which could indicate further price drops. If this selling trend persists, the stock may continue to decline as investor confidence weakens.

Recommendation changes over time:

Recommendations trend for APOLLOHOSP
Recommendations trend for APOLLOHOSP


Apollo Hospitals Enterprise Limited has been receiving a buy bias from analysts, indicating confidence in its investment potential. This could drive more investors to view Apollo Hospitals Enterprise Limited as a reliable choice for their money, offering a promising avenue for future growth and financial gains.